Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 24, 2023
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
[ Tue, Oct 24th 2023
] - WOPRAI
Mon, October 23, 2023
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
[ Mon, Oct 23rd 2023
] - WOPRAI
David Nierengarten Reiterated (STRO) at Buy and Held Target at $12 on, Oct 23rd, 2023
David Nierengarten of Wedbush, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $12 on, Oct 23rd, 2023.
David has made no other calls on STRO in the last 4 months.
There are 4 other peers that have a rating on STRO. Out of the 4 peers that are also analyzing STRO, 0 agree with David's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with David
- Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $10 on, Friday, October 6th, 2023
- Asthika Goonewardene of "Truist Securities" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, September 6th, 2023
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Monday, August 14th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $16 on, Friday, August 11th, 2023
